American International Group, Inc. Enochian Biosciences Inc Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $172 - $248	190 Added 2.03%	9,537 $8,000
Q4 2022 Feb 10, 2023	SELL	$1.03 - $2.13 $36 - $74	-35 Reduced 0.37%	9,347 $9,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.86 $226 - $380	133 Added 1.44%	9,382 $17,000
Q2 2022 Aug 12, 2022	BUY	$1.93 - $8.73 $17,850 - $80,743	9,249 New	9,249 $18,000
Q2 2021 Aug 13, 2021	SELL	$2.94 - $6.79 $23,634 - $54,584	-8,039 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.02 - $4.51 $63 - $94	21 Added 0.26%	8,039 $28,000
Q4 2020 Feb 12, 2021	SELL	$2.82 - $3.55 $648 - $816	-230 Reduced 2.79%	8,018 $24,000
Q3 2020 Nov 04, 2020	SELL	$3.42 - $4.55 $639 - $850	-187 Reduced 2.22%	8,248 $30,000
Q2 2020 Aug 12, 2020	BUY	$2.78 - $6.06 $786 - $1,714	283 Added 3.47%	8,435 $36,000
Q1 2020 May 04, 2020	SELL	$2.08 - $5.41 $981 - $2,553	-472 Reduced 5.47%	8,152 $24,000
Q4 2019 Feb 05, 2020	BUY	$3.48 - $6.75 $21,186 - $41,094	6,088 Added 240.06%	8,624 $43,000
Q3 2019 Nov 08, 2019	SELL	$3.95 - $5.72 $67 - $97	-17 Reduced 0.67%	2,536 $14,000
Q2 2019 Aug 13, 2019	BUY	$4.5 - $6.99 $11,488 - $17,845	2,553 New	2,553 $12,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.